Publicaciones en colaboración con investigadores/as de University of Birmingham (5)

2020

  1. Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial

    Leukemia, Vol. 34, Núm. 7, pp. 1760-1774

2018

  1. Tryptophan-Mediated Interactions between Tristetraprolin and the CNOT9 Subunit Are Required for CCR4-NOT Deadenylase Complex Recruitment

    Journal of Molecular Biology, Vol. 430, Núm. 5, pp. 722-736

2016

  1. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2014

  1. PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression

    Blood, Vol. 124, Núm. 24, pp. 3646-3655

2008

  1. Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus

    Human Gene Therapy, Vol. 19, Núm. 9, pp. 873-886